Early Cessation of Treatment Linked to Poorer Outcomes in Colorectal Cancer

Early cessation of all treatment (ETD) was linked to poorer outcomes in patients with stage 3 colorectal cancer treated with six months of oxaliplatin-based chemotherapy. In a study of 10,447 patients, ETD (but not early discontinuation of oxaliplatin only) was linked to decreases in survival.

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ